About
Jose “Pepe” Carmona has served as ADC Therapeutics' Chief Financial Officer since December 2022. He previously served as Chief Financial Officer of Rubius Therapeutics (2020-2022) and of Radius Health (2017-2020), and before that as Chief Financial Officer of Innocoll Holdings and of Alcon Europe, Middle East & Africa, a division of Novartis, after numerous financial management positions of increasing responsibility at Novartis. Mr. Carmona holds a B.S. in industrial civil engineering from Universidad Tecnica Federico Santa Maria and an M.B.A. from Columbia Business School.
Roles
ADC Therapeutics SA
Chief Financial Officer · Current role
December 2022–present
ADC Therapeutics
Chief Financial Officer
December 2022 - present
Rubius Therapeutics
Chief Financial Officer
October 2020 - November 2022
Radius Health
Chief Financial Officer
May 2017 - September 2020
Innocoll Holdings
Chief Financial Officer
—
Alcon (Novartis division)
Chief Financial Officer, Europe, Middle East & Africa
—
External Roles
Senda Biosciences
Board member
—
HotSpot Therapeutics
Board member
—
Fixed Compensation
FY 2025Salary
$525,208
ComponentAnnual base salary earned in fiscal 2025
All other compensation
$7,140
ComponentHealth, life and disability insurance, 401(k) matching contributions and other wellness benefits
Total compensation
$1,247,003
Performance Compensation
Data from FY 2025Cash incentive
Non-equity incentive plan compensation
$328,255
Target Opportunity
—
PlanAnnual cash incentive under the ADC Therapeutics Annual Bonus Plan
Stock awards
Stock awards
$386,400
FormRestricted stock units (RSUs), ASC 718 grant-date fair value
Also at ADC Therapeutics SA
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.